Another profitable year is in the books for investors. Whether you invested in 2025 or are looking to get started, this ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...
Run untrusted installers in a disposable Windows desktop. Add a simple config to lock it down, then close it to erase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback